10-49482798-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000124.4(ERCC6):c.2058G>A(p.Trp686*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,862 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000124.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- Cockayne spectrum with or without cerebrooculofacioskeletal syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Cockayne syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Myriad Women’s Health, Orphanet, Genomics England PanelApp, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- UV-sensitive syndrome 1Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- COFS syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- UV-sensitive syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- premature ovarian failure 11Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152010Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 727236 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152010Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74234 show subpopulations
ClinVar
Submissions by phenotype
Cockayne syndrome type 2 Pathogenic:2
The stop gain c.2058G>A (p.Trp686Ter) variant in ERCC6 gene has been reported in ClinVar as a pathogenic variant. The variant is novel (not in any individuals) in gnomAD Exomes and in 1000 Genomes. The nucleotide change c.2058G>A in ERCC6 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic. -
- -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Trp686*) in the ERCC6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC6 are known to be pathogenic (PMID: 18628313, 29572252). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of ERCC6-related conditions (PMID: 29915382). ClinVar contains an entry for this variant (Variation ID: 435083). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at